Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes
Cancer Cell · 2026
DOI: 10.1016/j.ccell.2026.03.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026. Verfasst von Lena Jassowicz und 42 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University,…. Hauptthemen laut MEDLINE: Breast Neoplasms, Brain Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Tumor Diseases Heidelberg, Norges Forskningsråd, Bundesministerium für Forschung, Technologie und Raumfahrt.
Abstract (Originalsprache)
Breast cancer brain metastases (BCBM) are a severe condition with high demand for improved personalized treatment, but a comprehensive understanding of BCBM immune-microenvironment heterogeneity and susceptibility to immunotherapy is lacking. Here, we multimodally profile the immune niche in a clinically well-annotated cohort of 156 BCBM applying tissue cytometry, bulk and single nuclei RNA-sequencing, flow cytometry, and spatial transcriptomics, complemented by functional studies in patient-derived models. Integrative analyses reveal two immune landscapes predicting prolonged patient survival and that are not deducible from paired primary tumors: 1) BCBM with a high proportion of CD8+ tissue-resident-like memory T cells as major players of tumor immune control. 2) BCBM containing tertiary lymphoid structures. Surrogate signatures of these landscapes are prognostic in independent BCBM and primary breast cancer cohorts, are associated with fewer metastases, and predict immunotherapy response. Our work provides critical insights into anti-tumor immunity in BCBM and identifies novel biomarkers with translational relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany; Division of Molecular Genetics, German Cancer Re…
- Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
- Department of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
- Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
- Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany; Department of Neurosurgery, Heidelberg Universit…
Förderung
- National Center for Tumor Diseases Heidelberg
- Norges Forskningsråd
- Bundesministerium für Forschung, Technologie und Raumfahrt
- Heidelberg University
- German José Carreras Foundation for Leucemia
- Dietmar Hopp Foundation
- Heidelberg University Medical Faculty Heidelberg
- Deutsche Krebshilfe
Zitieren
APA
Jassowicz, L., Feng, F., Warta, R., Heinicke, F., Wöllner, A., Briesch, H., Sor, F., Soller, J., Lotsch, C., Wong, J. K. L., Park, C. G., Aubert, N., Scheer, M., Hu, Z., Knoll, M., Schlegel, J., Frank, L., Dao Trong, P., Jungwirth, G., …, & Herold-Mende, C. (2026). Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.03.016
Vancouver
Jassowicz L, Feng F, Warta R, Heinicke F, Wöllner A, Briesch H, et al. Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.03.016
BibTeX
@article{Jassowicz2026,
author = {Jassowicz, Lena and Feng, Fangyoumin and Warta, Rolf and Heinicke, Fatima and Wöllner, Amélie and Briesch, Hannah and Sor, Furkan and Soller, Julia and Lotsch, Catharina and Wong, John K L and Park, Chang-Gyun and Aubert, Nicolas and Scheer, Maximilian and Hu, Zhaoqing and Knoll, Maximilian and Schlegel, Julian and Frank, Lukas and Dao Trong, Philip and Jungwirth, Gerhard and Nohman, Amin I and Maaß, Kendra and Grabe, Niels and Barthel, Mandy and Butz, Simone and Lulay, Christina and Zucknick, Manuela and Bortolomeazzi, Michele and Sant, Pooja and Thewes, Verena and Michel, Laura and Fremd, Carlo and Schneeweiss, Andreas and Sun, Chong and Rippe, Karsten and Abdollahi, Amir and von Deimling, Andreas and Unterberg, Andreas and Krieg, Sandro M and Mallm, Jan-Philipp and Lichter, Peter and Zapatka, Marc and Seiffert, Martina and Herold-Mende, Christel},
title = {Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes},
journal = {Cancer Cell},
year = {2026},
doi = {10.1016/j.ccell.2026.03.016}
}
EUVIMED